VD-1219

N/A

Report date: 2023/06/14 14:37:51
NME

Base Information

Drug NameVD-1219
Drug Alias NameVD1219VD-1219
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein modulatorsprotein allosteric modulators
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWeishen Pharmaceutical Technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWeishen Pharmaceutical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A